Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Acrivon Therapeutics, Inc. | 67,150 | reported | 18 May 2026 | tx 5+223,133−1,164 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 May 2026 | GRANT_AWARD | Acrivon Therapeutics, Inc. | 46,167 | 0.00 USD | |
| 01 Mar 2026 | GRANT_AWARD | Acrivon Therapeutics, Inc. | 132,925 | 0.00 USD | deriv |
| 14 Jan 2026 | PURCHASE | Acrivon Therapeutics, Inc. | 8,832 | 1.70 USD | |
| 01 Aug 2025 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 1,164 | 1.26 USD | |
| 01 Apr 2025 | GRANT_AWARD | Acrivon Therapeutics, Inc. | 35,209 | 0.00 USD | deriv |